Expression profiling of archival tumors for long-term health studies

Clinical Cancer Research

Volumn 18, Issue 22, 2012, Pages 6136-6146

  Waldron, Levi ^a,b   Ogino, Shuji ^a,c   Hoshida, Yujin ^e   Shima, Kaori ^a   Reed, Amy E McCart ^f   Simpson, Peter T ^f   Baba, Yoshifumi ^a   Nosho, Katsuhiko ^a   Segata, Nicola ^b   Vargas, Ana Cristina ^f   Cummings, Margaret C ^f,h   Lakhani, Sunil R ^f,g,h   Kirkner, Gregory J ^c   Giovannucci, Edward ^b,c   Quackenbush, John ^a   Golub, Todd R ^d   Fuchs, Charles S ^a,c   Parmigiani, Giovanni ^a,b   Huttenhower, Curtis ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF QUEENSLAND   (Australia)

^g UNIVERSITY OF QUEENSLAND   (Australia)

^h ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID SYNTHASE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN MLH1; SIRTUIN 1; TRANSCRIPTION FACTOR CDX2;

ARTICLE; BREAST CANCER; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FROZEN SECTION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIMIT OF QUANTITATION; MAJOR CLINICAL STUDY; METHODOLOGY; MICROSATELLITE INSTABILITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUALITY CONTROL; REPRODUCIBILITY; TISSUE MICROARRAY; VALIDATION PROCESS;

BREAST NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; FIXATIVES; FOLLOW-UP STUDIES; FORMALDEHYDE; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARAFFIN EMBEDDING; QUALITY CONTROL; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; TISSUE FIXATION; TRANSCRIPTOME;

EID: 84869214379     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-12-1915     Document Type: Article

References (35)

1. Williams PM, Li R, JohnsonNA, Wright G, Heath J-D,Gascoyne RD. A novel method of ampli fi cation of FFPET-derived RNA enables accurate disease classifi cation with microarrays. J Mol Diagn 2010;12:680-6.
2. Ogino S, Chan A, Fuchs C, Giovannucci E. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut 2011;60:397-808.
3. Ogino S, Galon J, Fuchs C, Dranoff G. Cancer immunology-analysis of host and tumor factors for personalized medicine. Nat Rev Clin Oncol 2011;8:711-20.
4. Lewis F, Maughan NJ, Smith V, Hillan K, Quirke P. Unlocking the archive-gene expression in paraffin-embedded tissue. J Pathol 2001;195:66-71. (Pubitemid 32899046)
5. Reinholz MM, Eckel-Passow JE, Anderson SK, Asmann YW, Zschunke MA, Oberg AL, et al. Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL platform. BMC Med Genomics 2010;3:60.
6. April C, Klotzle B, Royce T, Wickham-Garcia E, Boyaniwsky T, Izzo J, et al. Whole-genome gene expression profi ling of formalin-fixed, paraffin-embedded tissue samples. PLoS ONE 2009;4:e8162-e.
7. Ton CC, Vartanian N, Chai X, Lin MG, Yuan X, Malone KE, et al. Gene expression array testing of FFPE archival breast tumor samples: an optimized protocol for WG-DASL sample preparation. Breast Cancer Res Treat 2010;125:879-83.
8. Pillai R, Deeter R, Rigl CT, Nystrom JS, Miller MH, Buturovic L, et al. Validation and reproducibility of a microarray-based gene expression test for tumor identification in formalin- fixed, paraffin-embedded specimens. J Mol Diagn 2011;13:48-56.
9. Grenert JP, Smith A, Ruan W, Pillai R, Wu AHB. Gene expression profiling from formalin-fixed, paraffin-embedded tissue for tumor diagnosis. Clin Chim Acta 2011;4:e8162-e.
10. Waddell N, Cocciardi S, Johnson J, Healey S, Marsh A, Riley J, et al. Gene expression profiling of formalin-fixed, paraffi n-embedded familial breast tumours using the whole genome-DASL assay. J Pathol 2010;221:452-61.
11. Roberts L, Bowers J, Sensinger K, Lisowski A, Getts R, Anderson MG. Identifi cation of methods for use of formalin-fixed, paraffin-embedded tissue samples in RNA expression profiling. Genomics 2009;94:341-8.
12. Mittempergher L, de Ronde JJ, Nieuwland M, Kerkhoven RM, Simon I, Th. Rutgers EJ, et al. Gene expression profiles from formalin fixed paraf fin embedded breast cancer tissue are largely comparable to fresh frozen matched tissue. PLoS ONE 2011;6:e17163-e.
13. Lassmann S, Kreutz C, Schoepflin A, Hopt U, Timmer J, Werner M. A novel approach for reliable microarray analysis of microdissected tumor cells from formalin-fixed and paraf fin-embedded colorectal cancer resection specimens. J Mol Med 2008;87:211-24.
14. Coudry RA, Meireles SI, Stoyanova R, Cooper HS, Carpino A, Wang X, et al. Successful application of microarray technology to microdissected formalin-fixed, paraffin-embedded tissue. J Mol Diagn 2007;9:70-9. (Pubitemid 47322016)
15. Colditz GA, Hankinson SE. The Nurses' Health Study: lifestyle and health among women. Nat Rev Cancer 2005;5:388-96. (Pubitemid 40637830)
16. Morikawa T, Kuchiba A, Yamauchi M, Meyerhardt JA, Shima K, Nosho K, et al. Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer. JAMA 2011;305:1685-94.
17. Du P, Kibbe WA, Lin SM. lumi: a pipeline for processing Illumina microarray. Bioinformatics (Oxford, England) 2008;24:1547-8. (Pubitemid 351911712)
18. Sadi AM, Wang D-Y, Youngson BJ, Miller N, Boerner S, Done SJ, et al. Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimens. BMC Cancer 2011;11:1-13.
19. Jiang X, Tan J, Li J, Kivimae S, Yang X, Zhuang L, et al. DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications. Cancer Cell 2008;13:529-41. (Pubitemid 351766796)
20. Villanueva A, Hoshida Y, Battiston C, Tovar V, Sia D, Alsinet C, et al. Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology 2011;140:1501-12.
21. Minguez B, Hoshida Y, Villanueva A, Toffanin S, Cabellos L, Thung S, et al. Gene-expression signature of vascular invasion in hepatocellular carcinoma. J Hepatol 2011;55:1325-31.
22. Abdueva D, Wing M, Schaub B, Triche T, Davicioni E. Quantitative expression profiling in formalin-fixed paraffin-embedded samples by affymetrix microarrays. J Mol Diagn 2010;12:409-17.
23. Budczies J, Weichert W, Noske A, Muller BM, Weller C, Wittenberger T, et al. Genome-wide gene expression profiling of formalin-fixed paraffin-embedded breast cancer core biopsies using microarrays. J Histochem Cytochem 2011;59:146-57.
24. Hall JS, Leong HS, Armenoult LSC, Newton GE, Valentine HR, Irlam JJ, et al. Exon-array profiling unlocks clinically and biologically relevant gene signatures from formalin-fixed paraffin-embedded tumour samples. Br J Cancer 2011;104:971-81.
25. Collisson EA, Sadanandam A, Olson P, Gibb WJ, Truitt M, Gu S, et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat Med 2011;17:500-3.
26. Culhane AC, Schwarzl T, Sultana R, Picard KC, Picard SC, Lu TH, et al. GeneSigDB-a curated database of gene expression signatures. Nucleic Acids Res 2010;38:(Database issue):D716-25.
27. Irizarry R, Warren D, Spencer F, Kim I, Biswal S, Frank B, et al. Multiple-laboratory comparison of microarray platforms. Nat Meth 2005;2:345-50.
28. Kim H, Nam SW, Rhee H, Shan Li L, Ju Kang H, Hye Koh K, et al. Different gene expression profiles between microsatellite instability-high and microsatellite stable colorectal carcinomas. Oncogene 2004;23:6218-25. (Pubitemid 39215292)
29. Whole-Genome Gene Expression DASL Assay Guide. Illumina, Inc.; 2010 Mar. Catalog No.: DA-800-1002. Part No.: 11322443 Rev. B.
30. Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, Tibshirani R, et al. Missing value estimation methods for DNA microarrays. Bioinformatics 2001;17:520-5. (Pubitemid 32600498)
31. Conway C, Mitra A, Jewell R, Randerson-Moor J, Lobo S, Nsengimana J, et al. Gene expression profiling of paraf fi n-embedded primary melanoma using the DASL assay identifies increased osteopontin expression as predictive of reduced relapse-free survival. Clin Cancer Res 2009;15:6939-46.
32. Nagalakshmi U, Waern K, Snyder M. RNA-Seq: a method for comprehensive transcriptome analysis. Curr Protoc Mol Biol 2010;Chapter 4:Unit 4 11 1-3.
33. Koscielny S. Why most gene expression signatures of tumors have not been useful in the clinic. Sci Transl Med 2010;2:14ps2.
34. Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, Willett WC. Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst 1995;87:265-73.
35. Giovannucci E, Stampfer MJ, Colditz GA, Hunter DJ, Fuchs C, Rosner BA, et al. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med 1998;129:517-24. (Pubitemid 28460290)